Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase I Trial of Gene Vector to Patients With Retinal Disease Due to RPE65 Mutations (LCA)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00481546
First received: May 31, 2007
Last updated: March 3, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2026
  Estimated Primary Completion Date: June 2026 (Final data collection date for primary outcome measure)
Publications: